Therapy Areas: Devices
Moxe Health Raises USD 30m Series B to Further Advance Interoperability
2 June 2022 - - US-based healthcare interoperability specialist Moxe has closed a USD 30m funding round led by Piper Sandler Merchant Banking and Vensana Capital with participation from existing investors, the company said.

Moxe said it will use this funding to prioritize team expansion and technology investments to further advance its clinical data exchange solutions.

As part of the round, Tom Schnettler and Kirk Nielsen will join Moxe's board of directors. They will join existing investors from Safeguard Scientifics, UPMC Enterprises, 3M Ventures (the venture capital arm of 3M (NYSE: MMM)), and investors managed by Apollo.

Moxe empowers smarter, simpler, more secure data exchange for better healthcare.

Compatible with the leading EHRs, Moxe improves collaboration by digitizing medical charts and enabling bidirectional data exchange between providers, payers, and third-party requestors.

Moxe's API-first approach is revolutionizing the secure exchange of clinical information and putting actionable insights directly into the clinical workflow. Moxe solutions support risk adjustment, quality improvement, payment integrity, care management, and more. 

Piper Sandler Merchant Banking is the growth equity investment arm of Piper Sandler Companies (NYSE: PIPR).

PSMB provides investment advisory services through the affiliated registered investment adviser, PSC Capital Partners LLC. Learn more about Piper Sandler Merchant Banking.

Vensana Capital is a venture capital and growth equity investment firm.

Launched in 2019, Vensana manages USD 550m in capital and is actively investing in development and commercial stage companies across the medtech sector, including medical devices, diagnostics and data science, life science tools, digital health, and tech-enabled services.